安渡生物是專注于轉(zhuǎn)化科學(xué)和臨床開發(fā)的新一代科學(xué)導(dǎo)向型CRO。
作為中國(guó)布局最優(yōu)的全球化CRO之一,安渡生物為需要進(jìn)入多國(guó)市場(chǎng)的創(chuàng)新藥提供符合國(guó)際標(biāo)準(zhǔn)的轉(zhuǎn)化科學(xué)、定量臨床藥理、生物分析和生物標(biāo)志物、監(jiān)管申報(bào)和臨床開發(fā)全鏈條服務(wù),包括從臨床前到上市的臨床開發(fā)策略和執(zhí)行,科學(xué)地“選劑量、選靶點(diǎn)、選病人” ,運(yùn)用全球統(tǒng)一的技術(shù)平臺(tái)、管理體系和交付標(biāo)準(zhǔn),提高新藥研發(fā)效率和成功率??蛻羧后w涵蓋從頂尖的初創(chuàng)生物科技公司到跨國(guó)制藥企業(yè)。截至目前,安渡團(tuán)隊(duì)已經(jīng)成功為境內(nèi)外客戶在中美歐日完成超過(guò)210項(xiàng)入市申報(bào)(NDA,BLA,MAA)。
安渡生物已在全球多地設(shè)有運(yùn)營(yíng)設(shè)施,包括美國(guó)的加州普萊森頓(Pleasanton, CA)、密執(zhí)根州安娜堡(Ann Arbor, MI)、馬里蘭州德國(guó)鎮(zhèn)(Germantown, MD),中國(guó)的杭州、上海和北京,以及歐洲的比利時(shí)林堡?。↙imburg, Belgium)。
Amador Bioscience is a science-driven translational & clinical research CRO with established sites in USA, China and Europe.
As a leading partner for successful biopharmaceutical research and development, Amador Bioscience offers a comprehensive range of services, including translational sciences, clinical pharmacology, bioanalysis & biomarkers, regulatory strategy & submissions, and clinical research adhering to global standards. We excel in formulating and executing development strategies from pre-IND all the way to NDA/BLA/MAA submissions.
Our scientific methodologies to select the right target, right patient & right dose, and our global adoption of rigorous quality standards, serve to substantially enhance the efficiency and success rate of novel drug development endeavors.